Virology News

Health Ministry's Sharon Alroy-Preis urges vaccines against both viruses, noting that shots for influenza and coronavirus can be administered at the same time...

Leading sexual health expert predicts a gap of almost one month before supplies are replenished...

Denmark’s policy towards vaccination in the autumn of 2022 will focus on the over-50s.The under-50s will only get a...

Human alveolar and tracheobronchial epithelial air liquid interface (ALI) tissues are used as models to examine cellular responses to SARS-CoV-2 and influenza A virus infections and as antiviral drug screening assay platforms.

A polio vaccine booster program has been announced in the UK targeting all London children under the age of 10. The program comes after more detections of poliovirus in London’s wastewater indicate the virus is spreading undetected through the city.

Bharat Biotech's COVID-19 intranasal vaccine (BBV154) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials phase III.

CDC has reported two new human infections with a flu virus that usually spreads in pigs...

Broadly neutralizing antibodies (bNAbs) that bind to the hemagglutinin stalk domain
are an attractive therapeutic that protect against multiple strains of influenza virus.
Here, Zhang et al. demonstrate that neuraminidase inhibitors cooperate with both monoclonal and polyclonal bNAbs to protect...

Professor Shmuel C Shapira speaks from behind the scenes...

bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution...

OBJECTIVES: Patients with liver disease frequently require hospitalisation with infection often the trigger. Influenza vaccination is an effective infection prevention strategy in healthy and elderly but is often perceived less beneficial in patients with liver disease. We investigated whether influenza vaccination triggered serological response and prevented hospitalisation and death in liver disease.DESIGN: Systematic review and meta-analysis.DATA SOURCES: MEDLINE, EMBASE, PubMed and CENTRAL up to January 2019.ELIGIBILITY CRITERIA: Randomised or observational studies of the effects of influenza vaccine in adults with liver disease.DATA EXTRACTION AND SYNTHESIS: Two reviewers screened studies, extracted data and assessed risk of bias and quality of evidence. Primary outcomes were all-cause hospitalisation and mortality. Secondary outcomes were cause-specific hospitalisation and mortality, and serological vaccine response. Random-effects meta-analysis was used to estimate pooled effects of vaccination.RESULTS: We found 10 041 unique records, 286 were eligible for full-text review and 12 were included. Most patients had viral liver disease. All studies were of very low quality. Liver patients both with and without cirrhosis mounted an antibody response to influenza vaccination, and vaccination was associated with a reduction in risk of hospital admission from 205/1000 to 149/1000 (risk difference -0.06, 95% CI -0.07 to 0.04) in patients with viral liver disease. Vaccinated patients were 27% less likely to be admitted to hospital compared with unvaccinated patients (risk ratio 0.73, 95% CI 0.66 to 0.80). No effect against all-cause or cause-specific mortality or cause-specific hospitalisation was found.CONCLUSIONS: The low quantity and quality of the evidence means that the protective vaccine effect may be uncertain. Considering the high risk of serious health outcomes from influenza infection in patients with liver disease and the safety and low cost of vaccination, overall, the potential benefits of seasonal vaccination both to patients and the healthcare systems are likely to outweigh the costs and risks associated with vaccination.PROSPERO REGISTRATION NUMBER: CRD42017067277.

A crater from an asteroid scientists think hit Earth around the same time as the one that killed the dinosaurs brings up the question, "Are there others?"...

Thailand is set to lower the disease classification of the Wuhan coronavirus (COVID-19) beginning October, according to its Ministry of Public Health (MOPH). The MOPH said in a statement that COVID-19 will be downgraded from a “dangerous” communicable disease to one that “needs monitoring.” Under...

Widespread concerns about gamebird-shooting during the current avian flu epidemic are repeated today in an article in the Press & Journal.I argue that it's irresponsible and selfish for grouse-shoots to take place when the full impact of this highly pathogenic virus on our wild bird populations is...

Researchers find there are fewer poisonings from synthetic cannabinoids, also called K2 or spice, in states where cannabis is legal for recreational use.

New research clarifies why people defer to aggressive bosses despite not respecting them.

Bizarre underwater snow is known to occur on Earth, but a new study shows that the same is likely true for Jupiter's moon, Europa.

When ants get together, they make collective decisions a bit like networks of neurons in a brain, according to new research.

Bharat Biotech completed clinical trials of the nasal vaccine with about 4,000 volunteers and there is no side effect or adverse reaction reported so far...

Scientists have described the identification and therapeutic evaluation of an antibody that broadly neutralizes major variants of SARS-CoV-2, including the alpha, beta, delta, and omicron variants.

Russian director Kirill Serebrennikov has been invited to back-to-back Cannes for his latest work, premiering Petrov's Flu last year and Tchaikovsky's Wife this...